Novel broad spectrum inhibitors targeting the flavivirus methyltransferase

65Citations
Citations of this article
86Readers
Mendeley users who have this article in their library.

Abstract

The flavivirus methyltransferase (MTase) is an essential enzyme that sequentially methylates the N7 and 2'-O positions of the viral RNA cap, using S-adenosyl-L-methionine (SAM) as a methyl donor. We report here that small molecule compounds, which putatively bind to the SAM-binding site of flavivirus MTase and inhibit its function, were identified by using virtual screening. In vitro methylation experiments demonstrated significant MTase inhibition by 13 of these compounds, with the most potent compound displaying sub-micromolar inhibitory activity. The most active compounds showed broad spectrum activity against the MTase proteins of multiple flaviviruses. Two of these compounds also exhibited low cytotoxicity and effectively inhibited viral replication in cell-based assays, providing further structural insight into flavivirus MTase inhibition. Copyright:

Cite

CITATION STYLE

APA

Brecher, M., Chen, H., Liu, B., Banavali, N. K., Jones, S. A., Zhang, J., … Li, H. (2015). Novel broad spectrum inhibitors targeting the flavivirus methyltransferase. PLoS ONE, 10(6). https://doi.org/10.1371/journal.pone.0130062

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free